Japanese drugmaker Daiichi Sankyo has appointed Hiroyuki Okuzawa to succeed Sunao Manabe, as chief executive (CEO), effective April 1, 2025.

Five Oceans Advisors raised its position in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 11.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and ...

Crews Bank & Trust purchased a new position in AstraZeneca PLC (NASDAQ:AZN – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange ...